抗精神病药恶性综合征：综述
Neuroleptic malignant syndrome: a review.
作者信息
O'Brien R A, Young G B
出版信息
Can Fam Physician. 1989 May;35:1119-22.
Abstract
There has recently been interest in neuroleptic malignant syndrome (NMS) as the disorder has been better characterized. Nms is still poorly recognized, however, by most physicians. Hyperpyrexia, rigidity, altered consciousness, autonomic instability, and enzymatic evidence of muscle breakdown after drug intake are the cardinal features. The authors of this article review the proposed pathogenesis, complications, and treatment of NMS.
摘要
近年来，随着对神经阻滞剂恶性综合征（NMS）的特征有了更深入的了解，人们对它产生了兴趣。然而，大多数医生对NMS的认识仍然不足。高热、强直、意识改变、自主神经功能不稳定以及服药后肌肉分解的酶学证据是其主要特征。本文作者回顾了NMS的发病机制、并发症及治疗方法。
相似文献
1
Neuroleptic malignant syndrome: a review.抗精神病药恶性综合征：综述
Can Fam Physician. 1989 May;35:1119-22.
2
[Acute catatonic syndrome after neuroleptic malignant syndrome].[抗精神病药恶性综合征后的急性紧张症综合征]
Encephale. 2005 Nov-Dec;31(6 Pt 1):705-9. doi: 10.1016/s0013-7006(05)82429-7.
3
The neuroleptic malignant syndrome.抗精神病药恶性综合征
Arch Intern Med. 1982 Jun;142(6):1183-5.
4
Neuroleptic malignant syndrome with abnormally elevated cardiac troponin I: a case report.伴有异常升高的心肌肌钙蛋白I的抗精神病药恶性综合征：一例报告
J Int Med Res. 2020 Nov;48(11):300060520968344. doi: 10.1177/0300060520968344.
5
Neuroleptic rechallenge after neuroleptic malignant syndrome: case report and literature review.抗精神病药恶性综合征后的抗精神病药再次激发：病例报告及文献综述
Drug Intell Clin Pharm. 1988 Jun;22(6):475-80. doi: 10.1177/106002808802200606.
6
Metoclopramide-induced neuroleptic malignant syndrome.甲氧氯普胺所致的抗精神病药恶性综合征。
Arch Intern Med. 1987 Aug;147(8):1495-7.
7
Reconsidering Rigidity in the Diagnosis of Neuroleptic Malignant Syndrome: A Case Report.重新考虑神经安定剂恶性综合征诊断中的僵硬：病例报告。
J Psychiatr Pract. 2020 Jul;26(4):320-323. doi: 10.1097/PRA.0000000000000478.
8
Serotonin syndrome vs neuroleptic malignant syndrome: a contrast of causes, diagnoses, and management.血清素综合征与抗精神病药恶性综合征：病因、诊断及管理的对比
Ann Clin Psychiatry. 2012 May;24(2):155-62.
9
Coexistence of neuroleptic malignant syndrome and a hyperosmolar hyperglycemic state.抗精神病药恶性综合征与高渗性高血糖状态共存。
Am J Emerg Med. 2012 Jun;30(5):833.e1-2. doi: 10.1016/j.ajem.2011.02.031. Epub 2011 Apr 22.
10
A Neuroleptic Malignant Syndrome Without Rigidity.一种无强直的抗精神病药恶性综合征。
Psychiatry Investig. 2018 Feb;15(2):226-229. doi: 10.30773/pi.2017.06.05. Epub 2017 Dec 14.
本文引用的文献
1
Central nervous system reactions to small doses of tranquilizers; report of one death.小剂量镇静剂引起的中枢神经系统反应；一例死亡报告。
Am Pract Dig Treat. 1959 Apr;10(4):627-30.
2
A case of neuroleptic malignant syndrome successfully treated with amantadine.1例使用金刚烷胺成功治疗的抗精神病药恶性综合征病例。
J Clin Psychiatry. 1982 Sep;43(9):381-2.
3
Neuroleptic malignant syndrome: response to dantrolene sodium.抗精神病药恶性综合征：对丹曲林钠的反应
Ann Intern Med. 1983 Feb;98(2):183-4. doi: 10.7326/0003-4819-98-2-183.
4
Neuroleptic malignant syndrome associated with loxapine.与洛沙平相关的抗精神病药恶性综合征
J Clin Psychiatry. 1983 Jan;44(1):37-8.
5
Beneficial effects of dantrolene in the treatment of neuroleptic malignant syndrome: a report of two cases.
Neurology. 1983 Apr;33(4):516-8.
6
Neuroleptic malignant syndrome: successful treatment with dantrolene and bromocriptine.
Ann Neurol. 1983 Jul;14(1):89-90. doi: 10.1002/ana.410140117.
7
Neuroleptic malignant syndrome.抗精神病药恶性综合征
J Emerg Med. 1984;1(3):207-11. doi: 10.1016/0736-4679(84)90073-8.
8
Pharmacology of nomifensine: a review of animal studies.诺米芬辛的药理学：动物研究综述
J Clin Psychiatry. 1984 Apr;45(4 Pt 2):12-20.
9
Rapid development of tolerance to the hyperthermic effect of beta-endorphin, and cross-tolerance between the enkephalins and beta-endorphin.
Eur J Pharmacol. 1980 Jul 25;65(2-3):221-31. doi: 10.1016/0014-2999(80)90395-7.
10
Recurrent neuroleptic malignant syndrome due to tiapride and haloperidol: the possible role of D-2 dopamine receptors.由硫必利和氟哌啶醇引起的复发性神经阻滞剂恶性综合征：D-2多巴胺受体的可能作用。
J Nerv Ment Dis. 1984 Nov;172(11):692-5. doi: 10.1097/00005053-198411000-00008.
Zotero 插件